Literature DB >> 23702093

Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity.

Thomas D James1, Steven X Moffett, Thomas S Scanlan, Joseph V Martin.   

Abstract

The decarboxylated thyroid hormone derivative 3-iodothyronamine (T1AM) has been reported as having behavioral and physiological consequences distinct from those of thyroid hormones. Here, we investigate the effects of T1AM on EEG-defined sleep after acute administration to the preoptic region of adult male rats. Our laboratory recently demonstrated a decrease in EEG-defined sleep after administration of 3,3',5-triiodo-l-thyronine (T3) to the same brain region. After injection of T1AM or vehicle solution, EEG, EMG, activity, and core body temperature were recorded for 24h. Sleep parameters were determined from EEG and EMG data. Earlier investigations found contrasting systemic effects of T3 and T1AM, such as decreased heart rate and body temperature after intraperitoneal T1AM injection. However, nREM sleep was decreased in the present study after injections of 1 or 3 μg T1AM, but not after 0.3 or 10 μg, closely mimicking the previously reported effects of T3 administration to the preoptic region. The biphasic dose-response observed after either T1AM or T3 administration seems to indicate shared mechanisms and/or functions of sleep regulation in the preoptic region. Consistent with systemic administration of T1AM, however, microinjection of T1AM decreased body temperature. The current study is the first to show modulation of sleep by T1AM, and suggests that T1AM and T3 have both shared and independent effects in the adult mammalian brain.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23702093      PMCID: PMC4091812          DOI: 10.1016/j.yhbeh.2013.05.004

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  59 in total

1.  Sleep-waking discharge patterns of median preoptic nucleus neurons in rats.

Authors:  Natalia Suntsova; Ronald Szymusiak; Md Noor Alam; Ruben Guzman-Marin; Dennis McGinty
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 2.  Basal forebrain structures and sleep.

Authors:  M B Sterman; C D Clemente
Journal:  Acta Neurol Latinoam       Date:  1968

3.  Paradoxical effects of low doses of d-amphetamine in rats.

Authors:  S D Glick; R U Muller
Journal:  Psychopharmacologia       Date:  1971

4.  Relaxation and sleep induced by warming of preoptic region and anterior hypothalamus in cats.

Authors:  W W Roberts; T C Robinson
Journal:  Exp Neurol       Date:  1969-10       Impact factor: 5.330

5.  Sleep suppression after basal forebrain lesions in the cat.

Authors:  D J McGinty; M B Sterman
Journal:  Science       Date:  1968-06-14       Impact factor: 47.728

Review 6.  On the mechanism of action of thyroxin, an amino acid analog of tyrosine.

Authors:  M B Dratman
Journal:  J Theor Biol       Date:  1974-07       Impact factor: 2.691

7.  All night sleep studies in hypothyroid patients, before and after treatment.

Authors:  A Kales; G Heuser; A Jacobson; J D Kales; J Hanley; J R Zweizig; M J Paulson
Journal:  J Clin Endocrinol Metab       Date:  1967-11       Impact factor: 5.958

8.  Thyroid state: effects on pre- and postsynaptic central noradrenergic mechanisms.

Authors:  W Emlen; D S Segal; A J Mandell
Journal:  Science       Date:  1972-01-07       Impact factor: 47.728

Review 9.  Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.

Authors:  Mark D Berry
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

10.  Inhibition of the activity of the native gamma-aminobutyric acid A receptor by metabolites of thyroid hormones: correlations with molecular modeling studies.

Authors:  Joseph V Martin; J Michael Padron; M Andrew Newman; Richard Chapell; Nancy J Leidenheimer; Luke A Burke
Journal:  Brain Res       Date:  2004-04-09       Impact factor: 3.252

View more
  9 in total

1.  Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants.

Authors:  Ioannis Mantas; Mark J Millan; Benjamin Di Cara; Lucianne Groenink; Sylvie Veiga; Laetitia Cistarelli; Mauricette Brocco; Marc Bertrand; Per Svenningsson; Xiaoqun Zhang
Journal:  Int J Mol Sci       Date:  2021-08-18       Impact factor: 5.923

2.  The Hypothalamic Pituitary Thyroid Axis and Sleep.

Authors:  Skand Shekhar; Janet E Hall; Joanna Klubo-Gwiezdzinska
Journal:  Curr Opin Endocr Metab Res       Date:  2020-10-24

3.  Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.

Authors:  Juliane Dinter; Jessica Mühlhaus; Carolin Leonie Wienchol; Chun-Xia Yi; Daniela Nürnberg; Silke Morin; Annette Grüters; Josef Köhrle; Torsten Schöneberg; Matthias Tschöp; Heiko Krude; Gunnar Kleinau; Heike Biebermann
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 4.  Update on 3-iodothyronamine and its neurological and metabolic actions.

Authors:  Riccardo Zucchi; Alice Accorroni; Grazia Chiellini
Journal:  Front Physiol       Date:  2014-10-16       Impact factor: 4.566

5.  The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.

Authors:  Julia Bräunig; Juliane Dinter; Carolin S Höfig; Sarah Paisdzior; Michal Szczepek; Patrick Scheerer; Mark Rosowski; Jens Mittag; Gunnar Kleinau; Heike Biebermann
Journal:  Front Pharmacol       Date:  2018-03-12       Impact factor: 5.810

Review 6.  Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases.

Authors:  Annunziatina Laurino; Elisa Landucci; Laura Raimondi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-06       Impact factor: 5.555

Review 7.  The Case for TAAR1 as a Modulator of Central Nervous System Function.

Authors:  Grazia Rutigliano; Alice Accorroni; Riccardo Zucchi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

8.  L-3,3',5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors.

Authors:  Steven X Moffett; Eric A Klein; Grace Brannigan; Joseph V Martin
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

Review 9.  3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?

Authors:  Grazia Rutigliano; Lavinia Bandini; Simona Sestito; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2020-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.